Health Catalyst (HCAT) Tops Q2 EPS by 6c
Tweet
Share
E-mailHealth Catalyst (NASDAQ: HCAT) reported Q2 EPS of $0.05, $0.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.64 million.
For earnings history and earnings-related data on Health Catalyst (HCAT) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
